Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    L Histidine Hydrochloride Monohydrate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2COSENTYX

    02 1DARZALEX

    03 1GAMIFANT

    04 1IMJUDO

    05 1ONTRUZANT

    06 1OPDUALAG

    07 1SYLVANT

    08 1VYEPTI

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    ASTRAZENECA AB

    Tremelimumab-actl

    ISPE Annual Meeting
    Not Confirmed
    arrow

    02

    BRISTOL MYERS SQUIBB

    Nivolumab;Relatlimab-rmbw

    ISPE Annual Meeting
    Not Confirmed
    arrow

    03

    JANSSEN BIOTECH

    Daratumumab

    ISPE Annual Meeting
    Not Confirmed
    arrow

    04

    Lundbeck Seattle BioPharmaceuticals, Inc.

    Eptinezumab-jjmr

    ISPE Annual Meeting
    Not Confirmed
    arrow

    05

    NOVARTIS PHARMS CORP

    Secukinumab

    ISPE Annual Meeting
    Not Confirmed
    arrow

    06

    NOVARTIS PHARMS CORP

    Secukinumab

    ISPE Annual Meeting
    Not Confirmed
    arrow

    07

    NOVIMMUNE S.A.

    Emapalumab-lzsg

    ISPE Annual Meeting
    Not Confirmed
    arrow

    08

    SAMSUNG BIOEPIS CO LTD

    Trastuzumab-dttb

    ISPE Annual Meeting
    Not Confirmed
    arrow

    09

    RECORDATI RARE DISEASES, INC.

    Siltuximab

    ISPE Annual Meeting
    Not Confirmed
    arrow
    RECORDATI RARE DISEASES, INC.
    arrow
    ISPE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SILTUXIMAB

    Drug : SYLVANT

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 125496

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF